BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$3.51
-0.08 (-2.23%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+605.1% upside
Low Target
$18.09
Average Target
$24.75
High Target
$34.06
Current Price
$3.51
Current
$3.51
$3.51
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Scenario Analysis
Bear Case
$18.09
415.4%
Low target
Base Case
$24.75
+605.1%
Avg target
Bull Case
$34.06
+870.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$18.00
-80.5% from high
52-Week Low
$3.68
+-4.6% from low
Target vs 52W High
$24.75
+37.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |